(Q42536519)

1 November 2017

BM 17.0744: a structurally new antidiabetic compound with insulin-sensitizing and lipid-lowering activity (English)

1 reference

1 November 2017

Pill J

1

1 reference

PubMed ID

9920142

1 November 2017

Kühnle HF

series ordinal

2

1 reference

1 November 2017

1 January 1999

1 reference

1 November 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

1 November 2017

48

1 reference

1 November 2017

1

1 reference

1 November 2017

34-40

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

New therapeutic agents for the treatment of NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Section Review: Oncologic, Endocrine & Metabolic: Thiazolidinediones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Differences in the response of Sprague-Dawley and Lewis rats to bezafibrate: the hypolipidemic effect and the induction of peroxisomal enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Enzymatic determination of glucose and fructose simultaneously

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

The metabolic clearance of glucose: measurement and meaning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

A method for quantifying insulin sensitivity in vivo in the anesthetized rat : the euglycemic insulin clamp technique coupled with isotopic measurement of glucose turnover

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Zonal heterogeneity of peroxisome proliferation in rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Hormonal regulation of mammalian glucose transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Use of diphenylhydantoin and diazoxide to investigate insulin secretory mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Clinical use of diazoxide and mechanism for its hyperglycemic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Acute effects of troglitazone on in vivo insulin action in normal rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Structural diversity of peroxisome proliferators and their effects on mammalian liver cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

Thyromimetic effect of peroxisomal proliferators in rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990007-0

10.1016/S0026-0495(99)90007-0

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference

PubMed ID

9920142